tiprankstipranks
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
Holding ELTX?
Track your performance easily

Elicio Therapeutics (ELTX) Cash flow

196 Followers

Elicio Therapeutics Cash Flow

ELTX's free cash flow for Q3 2024 was $-7.27M. For the 2024 fiscal year, ELTX's free cash flow was decreased by $-9.89M and operating cash flow was $-7.27M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -33.51M$ -32.69M$ -22.18M$ -52.64M$ -22.89M$ -24.59M
Investing Cash Flow
$ -84.00K$ -32.00K$ -654.00K$ -382.00K$ -41.00K$ -242.00K
Financing Cash Flow
$ 42.15M$ 38.61M$ 21.20M$ 107.17M$ 52.41M$ 4.89M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 105.28M$ 14.30M$ 8.41M$ 88.76M$ 34.61M$ 5.57M
Income Tax Paid Supplemental Data
-----$ 0.00
Interest Paid Supplemental Data
---$ 7.00K$ 0.00$ 0.00
Issuance Of Capital Stock
$ 5.41M$ 7.00M-$ 107.49M$ 20.05M$ 0.00
Issuance Of Debt
$ 19.73M$ 10.00M$ -58.00K$ -9.00K$ 32.12M$ 5.26M
Repayment Of Debt
--$ -58.00K$ -9.00K--
Free Cash Flow
$ -33.59M$ -32.73M$ -22.83M$ -53.02M$ -22.93M$ -24.83M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Elicio Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis